查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1711260

2025年皮下给药装置全球市场报告

Subcutaneous Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年皮下给药装置市场规模将强劲成长。到 2029 年，这一数字将成长至 395.7 亿美元，复合年增长率为 7.4%。预测期内的成长可归因于生技药品和生物仿製药市场的成长、可穿戴药物输送系统的日益普及、个人化医疗的扩展、医疗报销政策的改善以及对家庭医疗保健的日益关注。预测期内的关键趋势包括数位健康技术的整合、智慧和连网型设备的发展、微创手术的兴起、无针注射系统的进步以及设备开发中人工智慧的兴起。

糖尿病和心血管疾病（CVD）盛行率的上升预计将推动皮下给药装置市场的扩张。这些疾病的增加主要是由于人口老化、饮食不良、久坐的生活方式、肥胖、社会经济差距、压力、环境因素以及预防性医疗保健机会有限。皮下给药装置广泛应用于糖尿病管理中，用于注射胰岛素和其他血糖控制药物，以及心血管疾病中，用于注射抗凝血剂和降脂剂等药物，为管理这些慢性疾病提供了一种方便、可控的方法。例如，英国慈善机构英国糖尿病协会 (Diabetes 英国 ) 在 2023 年 4 月报告称，英国目前有 430 万人患有糖尿病，2020-21 年和 2021-22 年期间新诊断病例增加了 148,951 例。此外，英国有超过 240 万人面临罹患第 2 型糖尿病的高风险。此外，美国疾病管制与预防中心（CDC）于2024年5月透露，2022年因心臟病死亡的人数将达到702,880人，占死亡人数的五分之一。因此，糖尿病和心血管疾病盛行率的上升正在推动皮下给药装置市场的成长。

皮下给药装置市场的关键参与者正专注于开发微型数位液体流量感测器等先进产品，以提高药物输送的安全性和准确性。这些感测器可以准确测量液体的流速，对于大容量注射器特别有用。例如，2024年5月，瑞士环境和流量感测器供应商Sensirion AG推出了其SLD3x系列感测器平台。该系列包括高精度数位液体流量感测器，具有可自订功能，可实现精确流量测量、堵塞检测、气泡识别和液体温度监测。这些微型感测器适用于大规模医疗设备製造，可确保最佳剂量并提高皮下给药的病患安全性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球皮下给药装置 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球皮下给药装置市场：成长率分析
  • 全球皮下给药装置市场表现：规模与成长，2019-2024
  • 全球皮下给药装置市场预测：规模与成长，2024-2029年，2034年
  • 全球皮下给药装置总目标市场（TAM）

第六章市场区隔

  • 全球皮下给药装置市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 胰岛素笔
  • 笔针
  • 注射笔
  • 自动注射器
  • 植入式帮浦
  • 全球皮下给药装置市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 糖尿病
  • 生育能力
  • 肿瘤学
  • 全球皮下给药装置市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 居家照护环境
  • 门诊手术中心
  • 全球皮下给药装置市场细分（按胰岛素笔类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 抛弃式胰岛素笔
  • 可重复使用的胰岛素笔
  • 全球皮下给药设备市场笔针细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 标准笔针
  • 安全笔针
  • 全球皮下给药设备市场，依注射笔类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 一次性注射笔
  • 可重复使用注射笔
  • 全球皮下给药装置市场自动注射器细分市场（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 手动自动注射器
  • 智慧型自动注射器
  • 全球皮下给药装置市场，依植入式帮浦类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 胰岛素帮浦
  • 药物输液泵

第七章 区域和国家分析

  • 全球皮下给药装置市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球皮下给药装置市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 皮下给药装置市场：竞争格局
  • 皮下给药装置市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Cook Medical Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Zoll Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Hollister Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Avanos Medical Inc.
  • Ambu A/S
  • Intersurgical Inc.
  • Vyaire Medical Inc.
  • Angiplast Pvt Ltd.
  • Amsino International Inc.
  • Inovet
  • GPC Medical Ltd.
  • CR Bard Inc.
  • Steroplast Healthcare Limited
  • Hitec Medical Co Ltd.
  • Sterimed Group
  • Neurovision Medical Products Inc.
  • Novo Klinik-Service GmbH
  • Well Lead Medical Co Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年皮下给药装置市场：提供新机会的国家
  • 2029年皮下给药装置市场：细分市场带来新机会
  • 皮下给药装置市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32285

Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue just beneath the skin. These devices are employed for delivering various drugs, including insulin, hormones, and biologics, offering a convenient and minimally invasive method of administration.

The main types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are handheld devices used for precise and convenient insulin administration in diabetes management, enabling users to easily measure and inject doses. These devices are used in various applications, such as diabetes, fertility, and oncology, and are utilized by different end-users, including hospitals, clinics, homecare settings, and ambulatory surgical centers.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $27.66 $ billion in 2024 to $29.77 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, growing demand for self-administration of drugs, the rise in diabetes and obesity rates, patient preference for convenient treatments, and the rising geriatric population.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $39.57 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growth in the biologics and biosimilars market, rising adoption of wearable drug delivery systems, expansion of personalized medicine, improving healthcare reimbursement policies, and growing emphasis on home healthcare. Major trends in the forecast period include the integration of digital health technologies, the development of smart and connected devices, the rise of minimally invasive procedures, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market. The rise in these conditions is largely due to aging populations, poor diets, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other medications for glycemic control, as well as in CVD to deliver drugs like anticoagulants or lipid-lowering agents, offering a convenient and controlled way to manage these chronic diseases. For example, in April 2023, the British Diabetic Association, a UK-based charity, reported that 4.3 million people in the UK are currently living with diabetes, with new diagnoses increasing by 148,951 from 2020-21 to 2021-22. Additionally, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Furthermore, in May 2024, the Centers for Disease Control and Prevention (CDC) in the U.S. revealed that heart disease caused 702,880 deaths in 2022, accounting for 1 in every 5 deaths. As a result, the rising prevalence of diabetes and cardiovascular diseases is driving the growth of the subcutaneous drug delivery devices market.

Key players in the subcutaneous drug delivery device market are concentrating on developing advanced products such as miniature digital liquid flow sensors to improve the safety and accuracy of drug delivery. These sensors provide precise measurements of liquid flow rates and are especially useful for large-volume injectors. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, introduced the SLD3x series sensor platform. This series includes highly accurate digital liquid flow sensors with customizable features, enabling precise flow measurement, occlusion detection, air bubble identification, and liquid temperature monitoring. These miniature sensors are suitable for large-scale medical device production, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for $0.960 billion. This acquisition aims to enhance Halozyme's biopharmaceutical capabilities by incorporating Antares' innovative drug delivery technologies and expanding its portfolio. The goal is to improve patient outcomes and accelerate the global development of Halozyme's ENHANZE technology. Antares Pharma Inc., also based in the US, specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
  • 2) By Application: Diabetes; Fertility; Oncology
  • 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
  • Subsegments:
  • 1) Insulin Pens: Disposable Insulin Pens; Reusable Insulin Pens
  • 2) Pen Needles: Standard Pen Needles; Safety Pen Needles
  • 3) Injector Pens: Disposable Injector Pens; Reusable Injector Pens
  • 4) Auto-Injectors: Manual Auto-Injectors; Smart Auto-Injectors
  • 5) Implantable Pumps: Insulin Pumps; Drug Infusion Pumps
  • Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Subcutaneous Drug Delivery Devices Market Characteristics

3. Subcutaneous Drug Delivery Devices Market Trends And Strategies

4. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Subcutaneous Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Subcutaneous Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Subcutaneous Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Subcutaneous Drug Delivery Devices Total Addressable Market (TAM)

6. Subcutaneous Drug Delivery Devices Market Segmentation

  • 6.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pens
  • Pen Needles
  • Injector Pens
  • Auto-Injectors
  • Implantable Pumps
  • 6.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes
  • Fertility
  • Oncology
  • 6.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals and Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • 6.4. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Insulin Pens
  • Reusable Insulin Pens
  • 6.5. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Pen Needles
  • Safety Pen Needles
  • 6.6. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Injector Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Injector Pens
  • Reusable Injector Pens
  • 6.7. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Auto-Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Auto-Injectors
  • Smart Auto-Injectors
  • 6.8. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Implantable Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pumps
  • Drug Infusion Pumps

7. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Subcutaneous Drug Delivery Devices Market

  • 8.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Subcutaneous Drug Delivery Devices Market

  • 9.1. China Subcutaneous Drug Delivery Devices Market Overview
  • 9.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Subcutaneous Drug Delivery Devices Market

  • 10.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Subcutaneous Drug Delivery Devices Market

  • 11.1. Japan Subcutaneous Drug Delivery Devices Market Overview
  • 11.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Subcutaneous Drug Delivery Devices Market

  • 12.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Subcutaneous Drug Delivery Devices Market

  • 13.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Subcutaneous Drug Delivery Devices Market

  • 14.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
  • 14.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Subcutaneous Drug Delivery Devices Market

  • 15.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
  • 15.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Subcutaneous Drug Delivery Devices Market

  • 16.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Subcutaneous Drug Delivery Devices Market

  • 17.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Subcutaneous Drug Delivery Devices Market

  • 18.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Subcutaneous Drug Delivery Devices Market

  • 19.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Subcutaneous Drug Delivery Devices Market

  • 20.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Subcutaneous Drug Delivery Devices Market

  • 21.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Subcutaneous Drug Delivery Devices Market

  • 22.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Subcutaneous Drug Delivery Devices Market

  • 23.1. North America Subcutaneous Drug Delivery Devices Market Overview
  • 23.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Subcutaneous Drug Delivery Devices Market

  • 24.1. USA Subcutaneous Drug Delivery Devices Market Overview
  • 24.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Subcutaneous Drug Delivery Devices Market

  • 25.1. Canada Subcutaneous Drug Delivery Devices Market Overview
  • 25.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Subcutaneous Drug Delivery Devices Market

  • 26.1. South America Subcutaneous Drug Delivery Devices Market Overview
  • 26.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Subcutaneous Drug Delivery Devices Market

  • 27.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Subcutaneous Drug Delivery Devices Market

  • 28.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
  • 28.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Subcutaneous Drug Delivery Devices Market

  • 29.1. Africa Subcutaneous Drug Delivery Devices Market Overview
  • 29.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape
  • 30.2. Subcutaneous Drug Delivery Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cook Medical Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zoll Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hollister Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Avanos Medical Inc.
  • 31.2. Ambu A/S
  • 31.3. Intersurgical Inc.
  • 31.4. Vyaire Medical Inc.
  • 31.5. Angiplast Pvt Ltd.
  • 31.6. Amsino International Inc.
  • 31.7. Inovet
  • 31.8. GPC Medical Ltd.
  • 31.9. C. R. Bard Inc.
  • 31.10. Steroplast Healthcare Limited
  • 31.11. Hitec Medical Co Ltd.
  • 31.12. Sterimed Group
  • 31.13. Neurovision Medical Products Inc.
  • 31.14. Novo Klinik-Service GmbH
  • 31.15. Well Lead Medical Co Ltd.

32. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

34. Recent Developments In The Subcutaneous Drug Delivery Devices Market

35. Subcutaneous Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Subcutaneous Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Subcutaneous Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Subcutaneous Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer